Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report

BACKGROUND: (Non-V600E) BRAF mutated colorectal cancer (CRC) is a rare disease entity with specific clinical features. These tumors are less likely to have microsatellite instability than CRC with a V600E BRAF mutation and often harbor a KRAS or NRAS mutation. Notably, median overall survival is lon...

Descripción completa

Detalles Bibliográficos
Autores principales: Callebout, Eduard, Ribeiro, Suzane Moura, Laurent, Stephanie, De Man, Marc, Ferdinande, Liesbeth, Claes, Kathleen B. M., Van der Meulen, Joni, Geboes, Karen P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560823/
https://www.ncbi.nlm.nih.gov/pubmed/31185985
http://dx.doi.org/10.1186/s12885-019-5763-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560823/
https://www.ncbi.nlm.nih.gov/pubmed/31185985
http://dx.doi.org/10.1186/s12885-019-5763-5

Ejemplares similares